US 9187530
Immunoregulatory peptides and methods of use
granted A61KA61K38/00A61K39/285
Quick answer
US patent 9187530 (Immunoregulatory peptides and methods of use) held by Compass Therapeutics LLC expires Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Compass Therapeutics LLC
- Grant date
- Tue Nov 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61K, A61K38/00, A61K39/285, A61P, A61P1/10